HomeProductsBioactive CompoundsTransporters & Ion ChannelsGABA ReceptorGaboxadol
Chemical structure of CAS 64603-91-4

Gaboxadol

CAS No.64603-91-4
MDL No.MFCD05664626
MFC6H8N2O2
MW140.14
InChI KeyZXRVKCBLGJOCEE-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

4,5,6,7-Tetrahydroisoxazolo(5,4-c)pyridin-3-ol is an oxazole.

CAS No.64603-91-4
Product NameGaboxadol

Biological Targets

GABRB3·GABRA4·GABRD

Associated Conditions

fragile X syndrome·Angelman syndrome·insomnia·major depressive disorder
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Opposite roles of GABA and excitatory amino acids on the control of GAD expression in cultured retina cells.

Brain research • Vol. 925, Issue 1 • 2002
PMID: 11755903DOI: 10.1016/s0006-8993(01)03265-6

trans-4-Amino-2-methylbut-2-enoic acid (2-MeTACA) and (+/-)-trans-2-aminomethylcyclopropanecarboxylic acid ((+/-)-TAMP) can differentiate rat rho3 from human rho1 and rho2 recombinant GABA(C) receptors.

British journal of pharmacology • Vol. 135, Issue 4 • 2002
PMID: 11861315PMC: PMC1573190DOI: 10.1038/sj.bjp.0704432

Characterisation of rat superficial superior colliculus neurones: firing properties and sensitivity to GABA.

Neuroscience • Vol. 110, Issue 1 • 2002
PMID: 11882375DOI: 10.1016/s0306-4522(01)00558-9

Entropy as the predominant driving force of binding to human recombinant alpha(x)beta(3)gamma(2) GABA(A) receptors.

European journal of pharmacology • Vol. 411, Issue 1-2 • 2001
PMID: 11137858DOI: 10.1016/s0014-2999(00)00898-0

Documentation